We are live on ! Find out more
EAM

EFG Asset Management Portfolio holdings

AUM $773M
1-Year Est. Return 40.1%
This Fund
S&P 500
This Quarter Est. Return
+13.25%
1 Year Est. Return
+40.1%
3 Year Est. Return
+211.13%
5 Year Est. Return
10 Year Est. Return
AUM
$466M
AUM Growth
+$13.7M
Cap. Flow
-$31.8M
Cap. Flow %
-6.83%
Top 10 Hldgs %
16.41%
Holding
209
New
30
Increased
54
Reduced
107
Closed
18

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$3.37M
2
ZG icon
Zillow
ZG
+$2.86M
3
U icon
Unity
U
+$2.84M
4
WAB icon
Wabtec
WAB
+$2.57M
5
NET icon
Cloudflare
NET
+$2.27M

Sector Composition

Rank Sector Weight
1 Healthcare 38.28%
2 Technology 22.29%
3 Consumer Discretionary 11.73%
4 Industrials 10%
5 Communication Services 7.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSLA icon
51
Tesla
TSLA
$1.2T
$3.21M 0.69%
12,280
-700
-5% -$140K
ZG icon
52
Zillow
ZG
$7.84B
$3.12M 0.67%
+63,368
New +$2.86M
DOCS icon
53
Doximity
DOCS
$3.91B
$2.9M 0.62%
85,302
+927
+1% +$30.9K
WAB icon
54
Wabtec
WAB
$50B
$2.84M 0.61%
+25,873
New +$2.57M
CRL icon
55
Charles River Laboratories
CRL
$11.4B
$2.79M 0.6%
13,258
+2,167
+20% +$431K
SRPT icon
56
Sarepta Therapeutics
SRPT
$1.66B
$2.78M 0.6%
24,294
+2,336
+11% +$301K
RCKT icon
57
Rocket Pharmaceuticals
RCKT
$336M
$2.78M 0.6%
140,023
+1,968
+1% +$39.8K
PRGO icon
58
Perrigo
PRGO
$1.42B
$2.74M 0.59%
80,792
-8,798
-10% -$306K
GTLS
59
DELISTED
Chart Industries
GTLS
$2.67M 0.57%
16,720
+3,635
+28% +$465K
INSP icon
60
Inspire Medical Systems
INSP
$1.49B
$2.64M 0.57%
8,121
+118
+1% +$33.7K
ONTO icon
61
Onto Innovation
ONTO
$11B
$2.63M 0.56%
22,621
-3,544
-14% -$338K
V icon
62
Visa
V
$707B
$2.54M 0.55%
10,710
-751
-7% -$172K
NET icon
63
Cloudflare
NET
$95.4B
$2.49M 0.53%
+38,020
New +$2.27M
RARE icon
64
Ultragenyx Pharmaceutical
RARE
$2.49B
$2.48M 0.53%
53,671
-5,758
-10% -$267K
WOLF icon
65
Wolfspeed
WOLF
$1.07B
$2.44M 0.52%
43,956
-2,651
-6% -$135K
META icon
66
Meta Platforms (Facebook)
META
$1.51T
$2.43M 0.52%
8,480
-425
-5% -$105K
WING icon
67
Wingstop
WING
$3.81B
$2.33M 0.5%
11,622
-688
-6% -$134K
GKOS icon
68
Glaukos
GKOS
$9.25B
$2.24M 0.48%
31,384
+2,818
+10% +$162K
WFRD icon
69
Weatherford International
WFRD
$5.99B
$2.13M 0.46%
32,111
-1,901
-6% -$117K
KRYS icon
70
Krystal Biotech
KRYS
$10.7B
$2.09M 0.45%
17,784
-3,065
-15% -$313K
SPSC icon
71
SPS Commerce
SPSC
$2.58B
$2.08M 0.45%
10,830
-478
-4% -$77.2K
ITCI
72
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$2.05M 0.44%
32,321
-1,912
-6% -$119K
NFLX icon
73
Netflix
NFLX
$304B
$2.02M 0.43%
45,780
+16,430
+56% +$605K
FOUR icon
74
Shift4
FOUR
$4.47B
$2.01M 0.43%
29,600
-3,138
-10% -$206K
MODN
75
DELISTED
MODEL N, INC.
MODN
$2.01M 0.43%
56,853
+3,869
+7% +$124K

Similar funds

EFG Asset Management's Q2 2023 Portfolio in Review

As of Q2 2023, EFG Asset Management held 209 positions worth $466M, up 3% from $452M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

EFG Asset Management withdrew a net $31.8M in Q2 2023, closing 18 positions and reducing 107 holdings. Its most notable exit was Seagen Inc. Common Stock, an estimated $9.28M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 40% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, EFG Asset Management opened a new position in Zillow worth $3.12M.

  • EFG Asset Management's largest Q2 2023 buy was Zillow: 63,368 shares worth $3.12M.
  • EFG Asset Management added most to BioMarin Pharmaceuticals in Q2 2023, an estimated $3.37M increase.
  • EFG Asset Management's biggest Q2 2023 reduction was Xencor, cutting an estimated $4.48M.
  • EFG Asset Management fully exited Seagen Inc. Common Stock in Q2 2023, selling an estimated $9.28M.
  • EFG Asset Management's ten largest holdings make up 16% of its $466M portfolio in Q2 2023.
  • EFG Asset Management opened 30 new positions and closed 18 in Q2 2023.
  • EFG Asset Management's portfolio value rose 3% quarter-over-quarter to $466M.

Based on EFG Asset Management's 13F filing for Q2 2023, filed 28 Jul 2023.